The U.S. Federal Trade Commission has sued to block Edwards Lifesciences Corp's acquisition of JenaValve Technology Inc, ...

The FTC asserts that Edwards acquisition of JenaValve, given it now owns rival TAVR-AR firm JC Medical, will eliminate ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

In its own statement, Edwards said it disagrees with the FTC’s belief that the acquisition will limit access to a new therapy ...

A year ago, three firms were racing to bring transcatheter aortic valve replacement devices to market. The FTC said allowing ...

FTC sues to block Edwards Lifesciences' $1.2B JenaValve deal. Edwards disputes, revises 2025 EPS guidance, and pursues ...

JenaValve Technology announced today that the U.S. Federal Trade Commission (FTC) moved to block the company’s proposed acquisition by Edwards Lifesciences. JenaValve respectfully disagrees with the ...

The Federal Trade Commission has moved to block Edwards Lifesciences’ proposed acquisition of medical-device company JenaValve Technology.The FTC said in a complaint filed Wednesday the acquisition ...

The Federal Trade Commission filed a lawsuit to prevent Edward LifeSciences from acquiring JenaValve Technology, arguing the deal would stifle innovation in treatments for aortic regurgitation, a ...

The JenaValve ALIGN-AR pivotal trial is ongoing in the United States, so patients with severe AR who are ineligible for surgery are currently treated with medical therapy, a left ventricular ...

Edwards Lifesciences (NYSE: EW) announced today that the U.S. Federal Trade Commission (FTC) moved to block the company’s proposed acquisition of JenaValve Technology.

Edwards Lifesciences announced that the U.S. Federal Trade Commission (FTC) seeks to block its planned $1.2 billion ...